Literature DB >> 20407478

The C3H/HeJ inbred mouse is a model of vesico-ureteric reflux with a susceptibility locus on chromosome 12.

Inga J Murawski1, Rita W Maina, Danielle Malo, Lisa M Guay-Woodford, Philippe Gros, Mary Fujiwara, Kenneth Morgan, Indra R Gupta.   

Abstract

Vesico-ureteric reflux is the most common congenital anomaly of the urinary tract, characterized by a defective uretero-vesical junction with retrograde urine flow from the bladder toward the kidneys. Because there is strong evidence for a genetic basis for some cases of vesico-ureteric reflux, we screened 11 inbred mouse strains for reflux and kidney size and identified one strain, C3H/HeJ, that has a 100 percent incidence of vesico-ureteric reflux with otherwise normal kidneys at birth. These mice are predisposed to reflux as a result of a defective uretero-vesical junction characterized by a short intravesical ureter. This defect results from a delay in urinary tract development initially manifested by a ureteric bud arising from a more caudal location along the mesonephric duct. In contrast, C57BL/6J mice (resistant to reflux at birth) have long intravesical ureters, normally positioned ureteric buds, and no delay in urinary tract development. Genome-wide and additional fine mapping of backcross mice, derived from C3H/HeJ and C57BL/6J crosses, identified a significant reflux susceptibility locus, Vurm1, on chromosome 12 (peak logarithm of the odds=7.39). The C3H/HeJ mouse is a model of vesico-ureteric reflux without renal malformation, and further characterization of this model will allow for the identification of a pathway important for urinary tract development, a finding that will serve as a model for the human disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20407478     DOI: 10.1038/ki.2010.110

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Androgens Enhance Male Urinary Tract Infection Severity in a New Model.

Authors:  Patrick D Olson; Keith A Hruska; David A Hunstad
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

Review 2.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

Review 3.  Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease.

Authors:  Marie-Lyne Fillion; Christine L Watt; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2014-02-06       Impact factor: 3.714

4.  Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome.

Authors:  Nan Yang; Nan Wu; Shuangshuang Dong; Ling Zhang; Yanxue Zhao; Weisheng Chen; Renqian Du; Chengcheng Song; Xiaojun Ren; Jiaqi Liu; Davut Pehlivan; Zhenlei Liu; Jia Rao; Chunyan Wang; Sen Zhao; Amy M Breman; Huadan Xue; Hao Sun; Jianxiong Shen; Shuyang Zhang; Jennifer E Posey; Hong Xu; Li Jin; Jianguo Zhang; Pengfei Liu; Simone Sanna-Cherchi; Guixing Qiu; Zhihong Wu; James R Lupski; Feng Zhang
Journal:  Kidney Int       Date:  2020-05-22       Impact factor: 10.612

5.  Vesico-ureteric reflux: using mouse models to understand a common congenital urinary tract defect.

Authors:  Inga J Murawski; Christine L Watt; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

6.  Inflammation drives renal scarring in experimental pyelonephritis.

Authors:  Birong Li; Babitha Haridas; Ashley R Jackson; Hanna Cortado; Nicholas Mayne; Rebecca Kohnken; Brad Bolon; Kirk M McHugh; Andrew L Schwaderer; John David Spencer; Christina B Ching; David S Hains; Sheryl S Justice; Santiago Partida-Sanchez; Brian Becknell
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-19

7.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.

Authors:  Makrina Totsika; Maria Kostakioti; Thomas J Hannan; Mathew Upton; Scott A Beatson; James W Janetka; Scott J Hultgren; Mark A Schembri
Journal:  J Infect Dis       Date:  2013-06-03       Impact factor: 5.226

10.  Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.

Authors:  Katherine Stewart; You Chi Tang; Maxwell E R Shafer; Adda-Lee Graham-Paquin; Maxime Bouchard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.